Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)

For efficient intranasal transport of parathyroid hormone (1-34) [PTH(1-34)], there is a great medical need to investigate permeation enhancers for intranasal formulations. In this study, the development of PTH(1-34) intranasal formulations was conducted. Based on conformation and chemical stability...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Deliv
Egile Nagusiak: Wang, Dan, Du, Yimeng, Zhang, Wenpeng, Han, Xiaolu, Zhang, Hui, Wang, Zengming, Liu, Nan, Li, Meng, Gao, Xiang, Zhuang, Xiaomei, Gao, Jing, Zheng, Aiping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7935113/
https://ncbi.nlm.nih.gov/pubmed/33657948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2021.1889718
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak